Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 8Neoplasms 6Hypogonadism 2Testicular Neoplasms 1Sexuality 1Osteoporosis 1Neoplasm Metastasis 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Fatigue 1Eunuchism 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1Arthralgia 1

Interventions

Carboplatin 15Etoposide 14Ifosfamide 11Paclitaxel 10Filgrastim 10Cisplatin 10Thiotepa 5Peripheral Blood Stem Cell Transplantation 5Gemcitabine 5pegfilgrastim 4Cyclophosphamide 4Bleomycin 4etoposide phosphate 3Oxaliplatin 3Methylprednisolone 3Epirubicin 3sargramostim 2aldesleukin 2Stem Cell Transplantation 2Prednisone 2Methotrexate 2Mesna 2Melphalan 2Granulocyte Colony-Stimulating Factor 2Docetaxel 2Dexamethasone 2Brentuximab Vedotin 2Arsenic Trioxide 2Amifostine 2Alemtuzumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Testicular Neoplasms × Testosterone × Clear all
NCT03339635 2024-07-30

Short-term Testosterone Replacement in Testicular Cancer Survivors

University Medical Center Groningen

Phase 2 Completed
32 enrolled
Genitourinary

Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡